Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Steven Deitcher
AddedMar 31, 2024
UpdatedMay 31, 2026
Steven Deitcher

Steven Deitcher

Co-Founder & CEO, Bespoke Biotherapeutics

CrunchbaseLinkedIn

Steven Deitcher's Career

Bespoke Biotherapeutics
Bespoke Biotherapeutics

San Mateo, CA, US

Co-Founder & CEO· C-Suite · Management
Radimmune Therapeutics
Radimmune Therapeutics

Tarrytown, NY, US

Board Member· Board
Medeor Therapeutics
Medeor Therapeutics

San Mateo, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Steven Deitcher's Career

Bespoke Biotherapeutics
Bespoke Biotherapeutics
Angel$256k22021San Mateo, CA, US
Co-Founder & CEO· C-Suite · Management

Leadership at Bespoke Biotherapeutics

Kirk TrislerKirk TrislerCo-Founder

Similar to Bespoke Biotherapeutics

Be BiopharmaBe BiopharmaCambridge, MA, USB Cell Therapiesest. 2020Be BiopharmaCambridge, MA, US · est. 2020

Be Bio: Innovating B cell therapies for advanced medical applications beyond cytotoxicity.

Series B · $182M119
Cellective BioTherapyCellective BioTherapyDurham, NC, USCancer Treatmentest. 2015Cellective BioTherapyDurham, NC, US · est. 2015

Cellective BioTherapy: Pioneering B cell-based therapies for personalized cancer treatment since 2015.

Angel · $2.5M7
Cell BioEnginesCell BioEnginesNew York City, NY, USCell Therapiesest. 2022Cell BioEnginesNew York City, NY, US · est. 2022

Cell BioEngines, Inc.: A clinical-stage biotech firm innovating cancer cures with scalable cell therapies.

Pre-Seed · $625k6
Fresh Wind Biotechnologies USAFresh Wind Biotechnologies USAHouston, TX, USCancer Therapiesest. 2020Fresh Wind Biotechnologies USAHouston, TX, US · est. 2020

Specializing in cellular immunotherapy, we engineer immune systems using genomic data to cure cancers.

Series A · $10M11
Radimmune Therapeutics
Radimmune Therapeutics
Series B$13.6M52016Tarrytown, NY, US
Board Member· Board

Leadership at Radimmune Therapeutics

David RicklesDavid RicklesCo-Founder
Josh BeckerJosh BeckerBoard Member
Ekaterina DadachovaEkaterina DadachovaCo-Founder
Medeor Therapeutics
Medeor Therapeutics
Series B$75.8M102012San Mateo, CA, US
Board Member· Board

Leadership at Medeor Therapeutics

Frank KungFrank KungBoard Member
Giovanni FerraraGiovanni FerraraCEO
Cp LiuCp LiuBoard Member
Peter KolchinskyPeter KolchinskyBoard Member
Anand MehraAnand MehraBoard Member
Wei LiWei LiBoard Member

Similar to Medeor Therapeutics

Tract TherapeuticsTract TherapeuticsChicago, IL, USMedicalest. 2013Tract TherapeuticsChicago, IL, US · est. 2013

Nova Biomedical: Innovating immune balance restoration for solid organ transplant patients.

Series B · $15M5
LTZ TherapeuticsLTZ TherapeuticsSan Francisco, CA, USImmunotherapy, Therapeuticsest. 2022LTZ TherapeuticsSan Francisco, CA, US · est. 2022

LTZ: Innovating immunotherapies for cancer and diseases with unmet clinical needs.

Seed · $27M16
Meditope BiosciencesMeditope BiosciencesPasadena, CA, USCancer Therapeuticsest. 2011Meditope BiosciencesPasadena, CA, US · est. 2011

Meditope Biosciences: Biotech firm specializing in antibody-based cancer treatments.

Series A · $3.6M6
SpheringenicsSpheringenicsAtlanta, GA, USCell Therapiesest. 2007SpheringenicsAtlanta, GA, US · est. 2007

SpherIngenics: Leading biotech firm specializing in innovative cell-based medicinal therapies.

Pre-Seed · $730k4

Steven Deitcher's Similar Executives & Operators

Achmad ZakyAchmad ZakyCo-Founder · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWillix HalimWillix HalimCEO · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakBo ZhangBo ZhangCo-Founder · DiDiWILL WEI CHENGWILL WEI CHENGBoard Member · DiDi

People Similar to Steven Deitcher

Rod DirRod DirCEO · Talon AerolyticsOfer Ben-NoonOfer Ben-NoonBoard Member · D-IDJeremy LappinJeremy LappinCo-Founder & CEO · CandexTim DuncanTim DuncanCo-Founder & CEO · Talos EnergyAnton KatzAnton KatzCo-Founder · TalosWinston DamarilloWinston DamarilloFounder & CEO · BayaniPay